CBT
TAK icon

CoreFirst Bank & Trust’s Takeda Pharmaceutical TAK Stock Holding History

CoreFirst Bank & Trust’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-203
Closed -$3.17K – 388
2022
Q4 		$3.17K Sell
203
-503
-71% -$7.03K ﹤0.01% 372
2022
Q3 		$9K Sell
706
-190
-21% -$2.64K 0.01% 334
2022
Q2 		$13K Sell
896
-8,450
-90% -$121K 0.01% 316
2022
Q1 		$134K Hold
9,346
– – 0.09% 159
2021
Q4 		$128K Hold
9,346
– – 0.08% 168
2021
Q3 		$154K Buy
9,346
+4,173
+81% +$70.1K 0.11% 154
2021
Q2 		$87K Hold
5,173
– – 0.06% 196
2021
Q1 		$94K Hold
5,173
– – 0.06% 186
2020
Q4 		$94K Buy
+5,173
New +$90.8K 0.07% 177

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return